Hennion & Walsh Asset Management, Inc. Ironwood Pharmaceuticals Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 129,649 shares of IRWD stock, worth $592,495. This represents 0.04% of its overall portfolio holdings.
Number of Shares
129,649
Previous 11,187
1058.93%
Holding current value
$592,495
Previous $97,000
771.13%
% of portfolio
0.04%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$105 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$98.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$74.9 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$42.2 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$40.7 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $700M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...